Garratt W. Ponder
Corporate Officer/Principal chez Tikvah Therapeutics, Inc.
Profil
Garratt W.
Ponder is Vice President of Pharmaceutical Development for Tikvah Therapeutics, Inc. Prior to joining Tikvah Therapeutics, he was Senior Director of Product Development for AtheroGenics, Inc. Before joining AtheroGenics in 2003, he worked at Endeavor Pharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. He has over 12 years of experience in analytical chemistry, process chemistry, and pharmaceutical development.
Dr. Ponder received a BS degree in Chemistry in 1989 and a PhD in Pharmaceutical Analysis from the University of Georgia in 1995.
Postes actifs de Garratt W. Ponder
| Sociétés | Poste | Début |
|---|---|---|
Tikvah Therapeutics, Inc.
 Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Tikvah Therapeutics, Inc. acquires, develops and commercializes therapeutics addressing medical needs relating to the central nervous system. Its products include TIK-101 (dCS) and TIK-201(NaPB). The company was founded in April 2006 and is located in Atlanta, GA. | Corporate Officer/Principal | - |
Anciens postes connus de Garratt W. Ponder
| Sociétés | Poste | Fin |
|---|---|---|
Endeavor Pharmaceuticals, Inc.
 Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Corporate Officer/Principal | - |
Solvay Pharmaceuticals, Inc.
 Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | Corporate Officer/Principal | - |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Corporate Officer/Principal | - |
Formation de Garratt W. Ponder
| University of Georgia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Tikvah Therapeutics, Inc. acquires, develops and commercializes therapeutics addressing medical needs relating to the central nervous system. Its products include TIK-101 (dCS) and TIK-201(NaPB). The company was founded in April 2006 and is located in Atlanta, GA. | Health Technology |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | Health Technology |
